---
schema_version: "secwatch.filing_event.v1"
accession: "0001472375-22-000082"
form_type: "8-K"
ticker: "RGPX"
cik: "0001357878"
company_name: "REGENEREX PHARMA, INC."
filed_at: "2022-08-26T23:59:59+00:00"
generated_at: "2026-06-23T20:53:38.468382+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Regenerex Pharma announces CFO, director resignations; appoints Lee Ori to board, Deborah Pilant as CFO

## Summary
- Irene Getty resigned as CFO, Bruce Sellars resigned from board, Byron Striloff resigned as officer, all effective Aug 25, 2022.
- Dr. Lee Ori appointed to board effective Aug 25; he also serves as COO. Background: pharmacy doctorate, Eli Lilly, multiple pharmacist licenses.
- Deborah L. Pilant appointed CFO effective Aug 25; already serving as Secretary/Treasurer and Director. Background in education, construction, sales.
- No reason given for departures or any financial impact disclosed.

## SEC filing metadata
- accession: 0001472375-22-000082
- form_type: 8-K
- ticker: RGPX
- cik: 0001357878
- company_name: REGENEREX PHARMA, INC.
- filed_at: 2022-08-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/0001472375-22-000082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/ixform8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001472375-22-000082
- JSON: https://secwatch.observer/filing/0001472375-22-000082.json
- Plain text: https://secwatch.observer/filing/0001472375-22-000082.txt

## Key facts
- Executive change
  Irene Getty resigned as Chief Financial Officer at REGENEREX PHARMA, INC..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: Effective August 25, 2022, Irene Getty tendered her letter of resignation to the Company resigning from her positions as Chief Financial Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/0001472375-22-000082-index.htm
- Executive change
  Bruce Sellars resigned as Director at REGENEREX PHARMA, INC..
  - Action: resigned
  - Role: Director
  source text: Effective August 25, 2022, Bruce Sellars tendered his letter of resignation to the Company resigning from his position as a member of the Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/0001472375-22-000082-index.htm
- Executive change
  Deborah L. Pilant was appointed as Chief Financial Officer at REGENEREX PHARMA, INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Effective August 25, 2022, Deborah L. Pilant has been appointed to serve as Chief Financial Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/0001472375-22-000082-index.htm
- Executive change
  Byron Striloff resigned as other_named_officer at REGENEREX PHARMA, INC..
  - Action: resigned
  source text: Effective August 25, 2022, Byron Striloff tendered his letter of resignation to the Company resigning from his position as an Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/0001472375-22-000082-index.htm
- Executive change
  Dr. Lee Ori was appointed as Director at REGENEREX PHARMA, INC..
  - Action: appointed
  - Role: Director
  source text: Effective August 25, 2022, Dr Lee Ori has been elected/appointed to the Board of Directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237522000082/0001472375-22-000082-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.